Search


Current filters:





Clear current filters  or Add more filters

View Option



Results 21-30 of 30 (Search time: 0.003 seconds).

  Combination chemotherapy with cisplatin-vinblastine in malignant mesothelioma (Journal article)

  'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer (Journal article)

  Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer (Journal article)

  Weekly paclitaxel combined with pegylated liposomal doxorubicin (CaelyxTM) given every 4 weeks: dose-finding and pharmacokinetic study in patients with advanced solid tumors (Journal article)

  Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study (Journal article)

  Docetaxel and carboplatin combination chemotherapy as outpatient palliative therapy in carcinoma of unknown primary: a multicentre Hellenic Cooperative Oncology Group phase II study (Journal article)

  Docetaxel in combination with dacarbazine in patients with advanced melanoma (Journal article)

  The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy (Journal article)

  Bcl2 and p53 protein expression in metastatic carcinoma of unknown primary origin: biological and clinical implications. A Hellenic Co-operative Oncology Group study (Journal article)

  Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1 (Journal article)